ACW actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis

  1. 43 Posts.
    lightbulb Created with Sketch. 49
    [email protected]

    Research paper published by the Actinogen team diving into the current literature on 11BHSD1 inhibition. They describe some potential future indications for Xanamem but nothing conclusive - the science is still quite unclear on this one unfortunately.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $82.60M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $22.66K 897.6K

Buyers (Bids)

No. Vol. Price($)
5 522475 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 650495 6
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.